Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support. [electronic resource]
Producer: 20160427Description: e002296 p. digitalISSN:- 1941-3297
- Adult
- Aged
- Anticoagulants -- adverse effects
- Aspirin -- adverse effects
- Chi-Square Distribution
- Dipyridamole -- adverse effects
- Disease-Free Survival
- Drug Therapy, Combination
- Female
- Heart Failure -- blood
- Heart-Assist Devices -- adverse effects
- Hemorrhage -- chemically induced
- Humans
- International Normalized Ratio
- Kaplan-Meier Estimate
- Linear Models
- Male
- Middle Aged
- Multivariate Analysis
- New York City -- epidemiology
- Platelet Aggregation Inhibitors -- adverse effects
- Prevalence
- Proportional Hazards Models
- Prosthesis Design
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Thrombosis -- diagnosis
- Time Factors
- Treatment Outcome
- Ventricular Function, Left
- Warfarin -- adverse effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.